1. Chen, Xilang, Chen, Jie, Feng, Weibo, Wu, Kaichun, Xia, Limin. 2023. FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC. In Theranostics, 13, 1401-1418. doi:10.7150/thno.82269. https://pubmed.ncbi.nlm.nih.gov/36923538/
2. Salinas, Sandra Andrea, Mace, Emily M, Conte, Matilde I, Lacorazza, H Daniel, Orange, Jordan S. 2022. An ELF4 hypomorphic variant results in NK cell deficiency. In JCI insight, 7, . doi:10.1172/jci.insight.155481. https://pubmed.ncbi.nlm.nih.gov/36477361/
3. Suico, Mary Ann, Shuto, Tsuyoshi, Kai, Hirofumi. . Roles and regulations of the ETS transcription factor ELF4/MEF. In Journal of molecular cell biology, 9, 168-177. doi:10.1093/jmcb/mjw051. https://pubmed.ncbi.nlm.nih.gov/27932483/
4. Cao, Meiwan, Chen, Peiyu, Peng, Baoling, Geng, Lanlan, Gong, Sitang. 2023. The transcription factor ELF4 alleviates inflammatory bowel disease by activating IL1RN transcription, suppressing inflammatory TH17 cell activity, and inducing macrophage M2 polarization. In Frontiers in immunology, 14, 1270411. doi:10.3389/fimmu.2023.1270411. https://pubmed.ncbi.nlm.nih.gov/38022496/
5. Kosti, Adam, Chiou, Jennifer, Guardia, Gabriela D A, Tiziani, Stefano, Penalva, Luiz O F. . ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics. In Neuro-oncology, 25, 459-470. doi:10.1093/neuonc/noac179. https://pubmed.ncbi.nlm.nih.gov/35862252/
智鼠故事 
